Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Octreotide: a therapeutic option for idiopathic intracranial hypertension.
Panagopoulos GN, Deftereos SN, Tagaris GA, Gryllia M, Kounadi T, Karamani O, Panagiotidis D, Koutiola-Pappa E, Karageorgiou CE, Piadites G. Panagopoulos GN, et al. Among authors: kounadi t. Neurol Neurophysiol Neurosci. 2007 Jul 10:1. Neurol Neurophysiol Neurosci. 2007. PMID: 17700925 Clinical Trial.
The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Piaditis GP, Hatziioanidis AH, Trovas GP, Misichronis GS, Kounadi TG, Devetzaki OA, Andronis CK, Rangou DB, Chlouverakis CS. Piaditis GP, et al. Among authors: kounadi tg. Clin Endocrinol (Oxf). 1996 Nov;45(5):595-604. doi: 10.1046/j.1365-2265.1996.00854.x. Clin Endocrinol (Oxf). 1996. PMID: 8977757
Surgery for pheochromocytoma: A 20-year experience of a single institution.
Aggeli C, Nixon AM, Parianos C, Vletsis G, Papanastasiou L, Markou A, Kounadi T, Piaditis G, Zografos GN. Aggeli C, et al. Among authors: kounadi t. Hormones (Athens). 2017 Oct;16(4):388-395. doi: 10.14310/horm.2002.1759. Hormones (Athens). 2017. PMID: 29518759 Free article.
Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
Papanastasiou L, Markou A, Pappa T, Gouli A, Tsounas P, Fountoulakis S, Kounadi T, Tsiama V, Dasou A, Gryparis A, Samara C, Zografos G, Kaltsas G, Chrousos G, Piaditis G. Papanastasiou L, et al. Among authors: kounadi t. Eur J Clin Invest. 2014 Aug;44(8):697-706. doi: 10.1111/eci.12286. Eur J Clin Invest. 2014. PMID: 24909545
Pre- and peri-operative characteristics, complications and outcomes of patients with biochemically silent pheochromocytomas; a case series.
Fountas A, Kanti G, Glycofridi S, Christou MA, Kalantzi A, Giagourta I, Markou A, Ntali G, Aggeli C, Saoulidou E, Dimakopoulou A, Zografos GN, Kounadi T, Tigas S, Papanastasiou L. Fountas A, et al. Among authors: kounadi t. Endocrine. 2022 Dec;78(3):570-579. doi: 10.1007/s12020-022-03182-w. Epub 2022 Sep 8. Endocrine. 2022. PMID: 36074243
Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G. Papanastasiou L, et al. Among authors: kounadi t. Clin Endocrinol (Oxf). 2017 Apr;86(4):488-498. doi: 10.1111/cen.13294. Epub 2017 Jan 25. Clin Endocrinol (Oxf). 2017. PMID: 27992961
30 results